Post-chemoreduction cryptic optic nerve relapse in a patient with bilateral retinoblastoma
In the presented case, the above tests provided no evidence of extraocular involvement. [...]staging, according to the UICC-AJCC TNM staging, was cT2N0M0. 6 Chemoreduction therapy, along with adjuvant focal treatments are regarded the treatment of choice for this stage of the disease.
Gespeichert in:
Veröffentlicht in: | British journal of ophthalmology 2013-02, Vol.97 (2), p.233-233 |
---|---|
Hauptverfasser: | , , , , , , , |
Format: | Artikel |
Sprache: | eng |
Schlagworte: | |
Online-Zugang: | Volltext |
Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
Zusammenfassung: | In the presented case, the above tests provided no evidence of extraocular involvement. [...]staging, according to the UICC-AJCC TNM staging, was cT2N0M0. 6 Chemoreduction therapy, along with adjuvant focal treatments are regarded the treatment of choice for this stage of the disease. |
---|---|
ISSN: | 0007-1161 1468-2079 |
DOI: | 10.1136/bjophthalmol-2012-302384 |